News
In a national study of older Danes who had previously had a fracture and were taking bisphosphonates, the risk of having a serious though rare atypical femoral fracture (AFF) was greater after 3 to 5 ...
4d
MedPage Today on MSNDrug Combo Fails to Cut Fracture Risk in Brittle Bone Disease
Among 350 adults with the condition, also known as brittle bone disease, the incidence of image-confirmed fractures didn't ...
5d
MedPage Today on MSNDrugs Boosts Bone Mineral Density in Premenopausal Osteoporosis
While rare, premenopausal idiopathic osteoporosis is marked by low BMD and fragility fractures in younger women who don't ...
Background and Objective: Despite their widespread use in metastatic bone disease, some bisphosphonate drugs are associated with adverse events (AEs), particularly renal toxicity, adding to treatment ...
Denosumab (Prolia) is a leading treatment for osteoporosis, but the rapid bone loss that can occur after discontinuing the RANK ligand inhibitor can be challenging to navigate. "I don't think we have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results